Nectar Lifesciences Limited — Important, 08-07-2025: General Updates

Nectar Lifesciences has announced a board meeting to discuss the financial results for the quarter and half-year. The Board addressed fines of Rs. 1.53 lakh each levied by NSE and BSE for delayed submission of financial results for the quarter and year ended March 31, 2025. The Company has paid the fines and requested a review for waiver. The Board has instructed management to ensure timely compliance going forward to avoid penalties and regulatory risks. No operational or business updates were disclosed.